1 |
Locksley RM, Killeen N, Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104;487-501, 2001
DOI
ScienceOn
|
2 |
Calderhead DM, Kosaka Y, Manning EM, Noelle RJ: CD40-CD154 interactions in B-cell signaling. Curr Top MicrobiolImmunol 245;73-99, 2000
|
3 |
Ishida TK, Tojo T, Aoki T, Kobayashi N, Ohishi T, Watanabe T, Yamamoto T, Inoue J: TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci USA 93;9437-9442, 1996
DOI
ScienceOn
|
4 |
Ishida T, Mizushima S, Azuma S, Kobayashi N, Tojo T, Suzuki K, Aizawa S, Watanabe T, Mosialos G, Kieff E, Yamamoto T, Inoue J: Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem 271;28745-29748, 1996
DOI
ScienceOn
|
5 |
Hsing Y, Hostager BS, Bishop GA: Characterization of CD40 signaling determinants regulating NF-B activation in lymphocytes. J Immunol 159;4898-4906, 1997
|
6 |
Rothe M, Sarma V, Dixit VM, Goeddel DV: TRAF2- mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269;1424-1427, 1995
DOI
ScienceOn
|
7 |
Bishop GA, Haughton G: Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen. Proc. Natl. Acad. Sci. (USA) 83;7410-414, 1986
DOI
ScienceOn
|
8 |
Zandvoort A, Lodewijk ME, de Boer NK, Dammers PM, Kroese FG, Timens W: CD27 expression in the human splenic marginal zone: the infant marginal zone is populated by naive B cells. Tissue Antigens 58;234-242, 2001
DOI
ScienceOn
|
9 |
van Lier RA, Borst J, Vroom TM, Klein H, Van Mourik P, Zeijlemaker WP, Melief CJ: Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol 139;1589-1596, 1987
|
10 |
Bishop GA: Requirements of class II-mediated B cell differentiation for class II crosslinking and cAMP. J Immunol. 147;1107-1114, 1991
PUBMED
|
11 |
Rothe M, Sarma V, Dixit VM, Goeddel DV: TRAF2- mediated activation of NF-kB by TNF receptor 2 and CD40. Science 269;1424-1427, 1995
DOI
ScienceOn
|
12 |
Brown KD, Hostager BS, Bishop GA: Regulation of TRAF2 signaling by self-induced degradation. J Biol Chem in press; 2002
|
13 |
Brink R, Lodish HF: Tumor necrosis factor receptor (TNFR)- associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2- mediated NF-kappaB activation. J Biol Chem 273;4129-4134, 1998
DOI
ScienceOn
|
14 |
Bradley JR, Pober JS: Tumor necrosis factor receptor- associated factors (TRAFs). Oncogene 20;6482-6491, 2001
DOI
ScienceOn
|
15 |
Nagumo H, Agematsu K, Shinozaki K, Hokibara S, Ito S, Takamoto M, Nikaido T, Yasui K, Uehara Y, Yachie A, Komiyama A: CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J Immunol 161;6496-6502, 1998
|
16 |
Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, Atsuta M, Morimoto C, Ware CF, Malinin NL, Wallach D, Yagita H, Okumura K: CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem 273;13353-13358, 1998
DOI
ScienceOn
|
17 |
Mercolino TJ, Arnold LW, Haughton G: Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes. J Exp Med 163;155-165, 1986
DOI
ScienceOn
|
18 |
Montixi C, Langlet C, Bernard AM, Thimonier J, Dubois C, Wurbel MA, Chauvin JP, Pierres M, He HT: Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J 17;5334-5348, 1998
DOI
ScienceOn
|
19 |
Ahonen C, Manning E, Erickson LD, O'Connor B, Lind EF, Pullen SS, Kehry MR, Noelle RJ: The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat Immunol 3;451-456, 2002
DOI
ScienceOn
|
20 |
Hostager BS, Bishop GA: Cutting Edge: Contrasting roles of TRAF2 and TRAF3 in CD40-mediated B lymphocyte activation. J Immunol 162;6307-6311, 1999
|
21 |
Hamano T, Kim KJ, Leiserson WM, Asofsky R: Establishment of B cell hybridomas with B cell surface antigens. J Immunol 129;1403-1406, 1982
|
22 |
Kobata T, Jacquot S, Kozlowski S, Agematsu K, Schlossman SF, Morimoto C: CD27-CD70 interactions regulate B-cell activation by T cells. Proc Natl Acad Sci USA 92;11249-11253, 1995
DOI
ScienceOn
|
23 |
Hostager BS, Catlett IM, Bishop GA: Recruitment of CD40, TRAF2 and TRAF3 to membrane microdomains during CD40 signaling. J Biol Chem 275;15392-15398, 2000
DOI
ScienceOn
|
24 |
Hu HM, O'Rourke K, Boguski MS, Dixit VM: A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 269;30069-30072, 1994
|
25 |
Brown KD, Hostager BS, Bishop GA: Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 193;943-954, 2001
DOI
ScienceOn
|
26 |
Klein U, Rajewsky K, Kuppers R: Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 188;1679-1689, 1998
DOI
ScienceOn
|
27 |
Maurer D, Holter W, Majdic O, Fischer GF, Knapp W: CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol 20;2679-2684, 1990
DOI
ScienceOn
|
28 |
Bishop GA, Hostager BS: Molecular mechanisms of CD40 signaling. Arch Immunol Ther Exp 49;129-137, 2001
|
29 |
Bishop GA, Warren WD, Berton MT: Signaling via MHC class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand. Eur J Immunol 25;1230-1238, 1995
DOI
ScienceOn
|
30 |
Warren WD, Berton MT: Induction of germ-line 1 and Ig gene expression in murine B cells. IL-4 and the CD40LCD40 interaction provide distinct but synergistic signals. J Immunol 155;5637-5646, 1995
|